Hosted by the International Low Grade Glioma Registry
Date: September 9, 2025
Time: 12:00 PM EDT
Duration: 45 minutes

On September 9, 2025, the International Low Grade Glioma Registry hosted a live webinar with Registry founder and neurosurgeon Dr. Elizabeth Claus on testing inherited (germline) cancer genes in people with glioma. Watch to learn why we perform this genetic testing and how it may impact care.

This webinar accompanies the Registry’s announcement that it is now offering free testing of germline cancer genes in persons with recurrent grade 2/3 glioma or any grade of IDH-mutant glioma who are participating in the OPTIMUM Study. If you are interested in this opportunity, please send us an email at glioma@yale.edu.

A recording of the webinar is accessible below.